Ms. Lehman is a founding partner of L3 with over 25 years of successful market development and commercialization experience in in vitro diagnostics (IVD) and medical devices. She has spent her career working with clinicians, scientists, laboratorians and healthcare executives spanning the hospital, physician office, urgent care and research market segments, as well as other technology sectors.
Since its founding, L3 has experienced continuous growth from its initial marketing services to offer market development, medical education and advisory services; pre-market services including clinical operations, quality and regulatory services; and, end-to-end trial services under its Clinical Research Organization (CRO), with the goal of having an upstream impact on clinical trial designs and study data that increase product value and acceptance in the market.
Prior to co-founding L3, Ms. Lehman held various leadership positions in marketing, distribution, sales and training, and has launched and managed multiple novel medical technology introductions that required innovative and thoughtful planning to gain market adoption and change clinical practice. As Director of Marketing at Accumetrics (now Accriva) she initiated a highly successfully national clinical educational campaign, re-engaged the medical advisory board and managed the distributor channel for the VerifyNow System. As Cardiovascular Product Director at Biosite (Alere, now Quidel) she managed the Triage cardiovascular product portfolio and launched the Triage D-dimer Test, which within 2 years became the top revenue producing D-dimer test on the market. As National POC IT Sales leader for Roche, where she helped establish and lead the sales division for hospital POC device connectivity. She has also helped developed various models to demonstrate the potential impact of novel products on clinical, operational and economic healthcare outcomes. Ms. Lehman earned her B.A. from the University of South Florida and resides with her husband in San Diego, CA.